Public annual accounts

PHARMACIE DU TAILLENY financials

Name: PHARMACIE DU TAILLENY financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for PHARMACIE DU TAILLENY, with comparable measures and links to available source documents.

Company overview

Registry number

0477352143

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for PHARMACIE DU TAILLENY

2025 versus 2024

Operating line: €413,341
EBITDA: €248,678
Total assets: €1,571,322
Equity: €1,129,963

EBITDA margin +60.2% · Equity ratio +71.9%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€413,341	€248,678	€1,571,322	€1,129,963	-
202431 Dec 2024	€434,098	€275,630	€1,512,209	€1,060,999	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€413,341

€248,678

€1,571,322

€1,129,963

202431 Dec 2024

€434,098

€275,630

€1,512,209

€1,060,999